Literature DB >> 22981217

Lung ventilation/perfusion scintigraphy in pulmonary capillary hemangiomatosis: a pattern to consider.

S Carmona1, M J Loureiro, J Santos, A Oliveira, R Camacho, A I Santos.   

Abstract

Pulmonary capillary hemangiomatosis is a rare disease, characterized by small capillaries proliferation, leading to pulmonary hypertension. The authors report a case of pulmonary capillary hemangiomatosis, and discuss its diagnostic difficulties. Special attention is presented to ventilation/perfusion scintigraphy, given both its importance to the evaluation of pulmonary hypertension, and its referred limited usefulness in pulmonary capillary hemangiomatosis. The few published cases of ventilation/perfusion scintigraphy on this entity have showed different patterns, which are discussed. This case presents a pattern with augmented perfusion on lung bases and normal ventilation, which has been described by other authors as typical for pulmonary capillary hemangiomatosis. The authors consider important to retain this pattern, when evaluating pulmonary hypertensive patients, given not only its possible ability to help on pulmonary capillary hemangiomatosis diagnosis, but also mainly its risk of misinterpretation as a decreased perfusion on upper lung lobes, leading to erroneous diagnostic hypotheses.
Copyright © 2012 Elsevier España, S.L. and SEMNIM. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981217     DOI: 10.1016/j.remn.2012.06.009

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN: 2253-654X            Impact factor:   1.359


  1 in total

1.  Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients.

Authors:  Briac Lefebvre; Maeva Kyheng; Jessica Giordano; Nicolas Lamblin; Pascal de Groote; Marie Fertin; Marie Delobelle; Thierry Perez; Jean-Baptiste Faivre; Jacques Remy; Alain Duhamel; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2022-03-14       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.